[Federal Register Volume 59, Number 100 (Wednesday, May 25, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-12754]


[[Page Unknown]]

[Federal Register: May 25, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Antitrust Division

 

Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--International Pharmaceutical Aerosol Consortium 
for Toxicology Testing of HFA-227

    Notice is hereby given that, on April 20, 1994, pursuant to section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), the International Pharmaceutical 
Aerosol Consortium for Toxicology Testing of HFA-227 (``IPACT-II'') 
filed written notifications simultaneously with the Attorney General 
and the Federal Trade Commission disclosing a change in its membership 
status. The notifications were filed for the purpose of extending the 
Act's provisions limiting the recovery of antitrust plaintiffs to 
actual damages under specified circumstances. Specifically, IPACT-II 
reinstated Schering-Plough Corporation, Madison, NJ as a member. 
Schering previously had terminated its membership in IPACT-II (58 FR 
25657). No other changes have been made in the membership, activities, 
or planned activity of IPACT-II.
    On February 21, 1991, IPACT-II filed its original notification 
pursuant to Section 6(b) of the Act. The Department of Justice 
published a notice in the Federal Register pursuant to section 6(b) of 
the Act on April 2, 1991 (56 FR 13489).
    The last notification was filed with the Department on January 14, 
1993. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on April 27, 1993 (58 FR 2567).
Constance K. Robinson,
Director of Operations Antitrust Division.
[FR Doc. 94-12754 Filed 5-24-94; 8:45 am]
BILLING CODE 4410-01-M